首页 | 本学科首页   官方微博 | 高级检索  
检索        

补肺汤治疗支气管哮喘的临床观察
引用本文:邓鸥鸥,张伟彬,朱辉军.补肺汤治疗支气管哮喘的临床观察[J].中医临床研究,2013,0(15):16-17.
作者姓名:邓鸥鸥  张伟彬  朱辉军
作者单位:1. 东莞市樟木头医院,广东 东莞,523633
2. 深圳市南山人民医院,广东 深圳,518052
摘    要:目的:探讨补肺汤治疗支气管哮喘的临床效果。方法:支气管哮喘患者80例,根据治疗方法的不同分为治疗组与对照组各40例,两组都常规给予抗炎、解痉、糖皮质激素应用。治疗组在此基础上治疗组加用补肺汤治疗。结果:治疗组有效率为97.5%,对照组有效率为85.0%,治疗组的疗效明显好于对照组(P<0.05)。治疗后治疗组的IL-8和IFN-γ值明显低于对照组, IL-4值明显高于对照组,差异都有统计学意义(P<0.05)。结论:补肺汤治疗支气管哮喘能提高治疗疗效,其疗效机制的发挥可能与改善气道炎症因子有关。

关 键 词:补肺汤  支气管哮喘  炎症因子

Clinical observation on treating bronchial asthma with the Bufei decoction
Abstract:Objective: To investigate the clinical effects of the Bufei decoction treatment of bronchial asthma. Methods: 80 cases of patients with bronchial asthma divided into the treated group and the control group, 40 cases in each based on different methods of treated, the two groups are routine given anti-inflammatory, antispasmodic, glucocorticoid application. Treated group on the basis of the treated group and Bufei decoction treated. Results: The response rate was 97.5%, the efficiency was 85.0% in the control group, the efficacy of the treated group was significantly better than the control group (P〈0.05). The treated group IL-8 and IFN-? was significantly less than that of the control group, the IL-4 was significantly higher than that in the control group, the differences were statistically significant (P〈0.05). Conclusion: The Bufei decoction in the treated of bronchial asthma can improve the therapeutic efficacy, the play of its efficacy mechanism may be related to with improved airway inflammation factor.
Keywords:Bufei decoction  Bronchial asthma  Inflammatory cytokines
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号